Shareholder alert: robbins llp reminds investors that acelrx pharmaceuticals, inc. (acrx) is being sued for misleading shareholders

San diego & hayward, calif.--(business wire)---- $acrx #acelrx--shareholder rights law firm robbins llp reminds investors that a class action has been filed on behalf of all purchasers of acelrx therapeutics, inc. (nasdaq:acrx) securities between march 17, 2020 and february 12, 2021, against the company for remedies under the securities exchange act of 1934. acelrx is a pharmaceutical company that develops and commercializes therapies for the treatment of acute pain. the company's lead product candidate is dsuvi
ACRX Ratings Summary
ACRX Quant Ranking